Presentations Acute Management of Hyperkalemia: What We Know & What We Need to Know AKI Management in the Developing World AKI: Past, Present and Future (Part I) AKI: Past, Present and Future (Part II) Anatomical and Functional Imaging of CAD in CKD Anemia in CKD. The 2019 KDIGO Standpoint. Anti-Glycemic Agents in 2019: Beyond Glucose Control Aortic Aneurysms and Dissections – What is Special in CKD? Appropriate Dialysis Access Are we Listening? Patient Experiences and Symptoms as They Relate to Volume and Blood Pressure Management Blood Pressure in CKD. The KDIGO 2019 Standpoint. Blood Pressure Measurement, Targets, and Pharmacologic Management Bone Fractures CAD in CKD / ESKD — A Wolf in Sheep’s Clothing? Can we predict the onset of ESRD? Cardiac-Specific Biomarkers for Diagnosis & Prognosis in Patients with Kidney Disease: The Past, Present and Future Cardiovascular and Chronic Kidney Disease Care of transition period in Korean patients with CKD CKD in Asia: What is Common and What is Different from the West? CKD-Associated Pruritus Controversies In Optimal Iron Use For CKD Anemia Management: Snapshot Of A 2019 KDIGO Conference Controversies in the Treatment of ANCA-Associated Vasculitis Cost Effectiveness of CKD-MBD Management in Japan Cost-effectiveness of DAA Therapies: Examples Drawn from Asian Countries Current Clinical Trials in Treating IgAN Current Evidence & Future Perspectives in Non-Dietary Management of Chronic Hyperkalemia Current Global & Regional Epidemiology of HCV Infection in Hemodialysis Units: Strategies for Preventing Transmission Current therapies in diabetic kidney disease Diabetes Management in Chronic Kidney Disease Diagnosis and Management of HCV-related GN Diagnostic tests and therapeutic targets for anemia of CKD Dialysis Dosing: Kinetics Versus Physiology Dialysis Initiation: Offering Real Choice and Adequate Preparation for Patients Facing Kidney Failure Dietary Interventions for Potassium Management Dietary Phosphate Intake Patterns in HD Patients: Understanding Determinants of Patient Behaviors Epidemiology of Central & Peripheral Arterial Diseases in CKD Epidemiology, Diagnosis, and Management of Renovascular Disease Evidence Base for Management of Hypokalemia in ER, CKD, and Dialysis Patients Fluid / Electrolyte Disturbances Associated with Cancer Future Therapies for AKI – what’s likely to make it into the clinic? Global & Regional Epidemiology of HCV: Pathways to Its Elimination by 2030 Global Burden of AKI Global Burden of Dialysis Initiation HCV-Positive ESKD Patient: Isolated Kidney versus Combined Kidney-Liver Transplantation? Health Economics, Healthcare Payers, Guidelines and the Inherent Tension: can they ever agree? Heart failure in chronic kidney disease Heart Failure in Chronic Kidney Disease Hemodynamic Consequences of Dialysis HIF-PHI for Anemia in Patients with Kidney Disease Not Receiving Dialysis HIV–associated nephropathy (HIVAN) Home Therapies (Home HD & PD) Prescriptions as they Relate to Blood Pressure and Volume Home-First Dialysis How to Change Physician, Health System and Patient Behavior: the Knowledge to Action Cycle and Guideline Implementation How to Merge and Compare Cohort Studies – CRIC & CKD-JAC Hypoxia-inducible-factors in erythropoiesis, iron homeostasis and beyond Identifying and Overcoming Barriers to Guideline Implementation Impact of HCV on CKD Progression and Associated Comorbidities Importance of Vascular Disease and What is New In Vivo Responses of Phosphorus-based Food with Different Forms in Mice Iron Deficiency Anemia: from the Cardiologist Perspective Iron Deficiency Anemia: from the Nephrologist Perspective Iron homeostasis regulation and role in health and disease Iron therapy for managing anemia in CKD: formulations, dosing, benefits and cautions KDIGO-Arkana 2022 Pathology Slide Set based on the KDIGO 2021 GD Guideline KDIGO CKD-MBD Guideline Update KDIGO Controversies Conference on Glomerular Diseases 2017: A summary KDIGO Controversies Conference on Onco-Nephrology: What’s new for us? KDIGO Guideline Update on Hepatitis C in CKD: New Evidence, New Recommendations KDIGO Introduction KDIGO Webinar on Nomenclature for Kidney Function & Disease: Implications for Researchers, Clinical Educators and Practitioners KDIGO: Guias Mundiales de Práctica Clínica en Nefrología KDIGO: What Is It and Why Is It Important? Kidney Problems in Anti-Cancer Treatment Kidney, Heart, and Vasculature Conference Series Overview Lessons Acquired from HCV Outbreaks in Hemodialysis Units Management and Treatment of Glomerular Diseases: Highlights of the New KDIGO 2020 Guideline Management of CKD and AKI in Malignancy Management of Hyperkalaemia Managing Acute & Chronic Hyperkalemia: Solving the Puzzle Membranous Nephropathy Models of Care Multidisciplinary Care for AKI New and emerging therapies for anemia of CKD Non-Embolic and Embolic Mechanisms of Stroke Novel Treatments for Solid-Organ & Hematologic Malignancies Nutritional Management in CKD-MBD Onco-Nephrology: Perspectives from Nephrology and Oncology Opportunities to Harness Technology to Improve Blood Pressure and Volume Management in Maintenance Dialysis Overview of the 2017 KDIGO CKD-MBD Guideline: A Focus on SHPT & Hyperphosphatemia PAD from a Renal Perspective Pathogenesis & Prognosis of ANCA Vasculitis Pathophysiology of Vascular Calcification Patient and Caregiver Perspectives on the Definitions and Impact of Terms Used to Describe Kidney Health Patient Perspective and Symptom Control in Dialysis Initiation Perspectives from an AKI Survivor Pharmacologic treatment of chronic hyperkalemia in CKD Physiology of K Homeostasis Population Screening Potassium Controversies Potassium Management Potassium Management: Observations from a KDIGO Controversies Conference Precision Medicine: Towards a Mechanistic Definition of Kidney Disease Preventing AKI in Cardiac Surgery Recent Approach of KDIGO to CKD-CVD Renal Involvement in Hematological Disorders Reno-Protective Effect of SGLT2 Inhibitors Screening, Diagnosis, and Assessment of Liver Disease in CKD Patients with HCV System Perspectives & Health Economics Testing, Incidence and Outcomes of Cardiac Disease in Kidney Transplant Candidates The AMA Manual of Style Perspective The Crisis of AKI Follow-Up The In-Center Hemodialysis Prescription as it Relates to Blood Pressure and Volume The KDIGO AKI Guidelines: from 2011-2019 The KDIGO Diabetes Guidelines – Implications for the practicing nephrologist The Patient Perspective The Perceived vs Real Importance of Hyperkalemia in CV Practice Towards the Implementation of the 2018 KDIGO Guideline on Hepatitis C in CKD Treatment Challenges in Special Populations Treatment of HCV in Kidney Transplant Recipients Treatment Strategies for Chronic HCV in CKD G4 and G5 Including Dialysis (HD and PD) Update on randomized clinical trials in anemia of CKD Valvular Disease in CKD / ESKD What do we know about available kidney measures and their value for detecting CKD and discriminating Stage and Prognosis? What’s new in the 2017 KDIGO CKD MBD Guideline? When to Treat HCV – Before or After a Kidney Transplant?